Background:Breast cancer remains a leading cause of morbidity and mortality among women worldwide,with significant geographic disparities in its impact.While human epidermal growth factor receptor 2(HER2)-targeted the...Background:Breast cancer remains a leading cause of morbidity and mortality among women worldwide,with significant geographic disparities in its impact.While human epidermal growth factor receptor 2(HER2)-targeted therapies,such as trastuzumab,have improved outcomes for HER2-positive breast cancer,challenges like therapy resistance persist,highlighting the need for novel treatments.Recent developments in antibody-drug conjugates(ADCs),particularly disitamab vedotin(RC48),show promising efficacy in targeting both HER2-positive and HER2-low expression tumors,warranting further investigation through real-world studies to assess its broader clinical applicability.Method:This retrospective,multicenter observational study evaluated the real-world efficacy and safety of RC48 in patients with HER2-positive or HER2-low breast cancer across three medical centers in China.Patient demographic characteristics,treatment patterns,sequential use of ADCs,and treatment-related adverse events were recorded and analyzed.Result:The median progression-free survival(mPFS)for the overall population(n 96)was=4.31 months,with HER2-positive patients demonstrating significantly longer mPFS(5.26 months)compared to HER2-low patients(3.45 months;p<0.044),while subgroup analyses revealed no significant differences in mPFS based on=estrogen receptor(ER),progesterone receptor(PR),or hormone receptor(HR)status.Safety data indicated that adverse events were consistent with prior reports,with no new safety concerns identified during the study period.Conclusion:This real-world study demonstrates the efficacy of RC48 in both HER2-positive and HER2-low breast cancer.Notably,combination therapy significantly improved outcomes in HER2-low patients.展开更多
The principal breast cancer treatment approach has long been surgical removal of the primary breast lesions and regional lymph nodes,particularly the axillary lymph nodes.However,the advent of minimally invasive diagn...The principal breast cancer treatment approach has long been surgical removal of the primary breast lesions and regional lymph nodes,particularly the axillary lymph nodes.However,the advent of minimally invasive diagnostic techniques,such as sentinel lymph node biopsy(SLNB),has markedly diminished the extent of surgery required for regional lymph nodes.展开更多
Objective: To investigate histo-pathological distribution and clinico-pathological significance in a large Chinese triple-negative breast cancer(TNBC) patients serials based on the latest understanding of its clinico-...Objective: To investigate histo-pathological distribution and clinico-pathological significance in a large Chinese triple-negative breast cancer(TNBC) patients serials based on the latest understanding of its clinico-pathological diversity, and to provide more information to clinicians to improve precision of individualized treatment of TNBC.Methods: A retrospective analysis was performed on patients with TNBC at Breast Disease Center, Peking University First Hospital between January 2010 and December 2019. Histo-and clinico-pathological characteristics were analyzed by Chi-square test and Student's t-test, and prognoses were calculated using KaplanMeier method and a Cox proportionate hazards model. Bonferroni correction was used to correct for multiple comparison.Results: Conventional type of TNBC(c TNBC) were identified in 73.7% of 582 TNBC, while special type of TNBC(s TNBC) were 26.3%, including 71 apocrine carcinoma, 20 medullary carcinoma, 31 metaplastic carcinoma, 18 invasive lobular carcinoma, 7 invasive micropapillary carcinoma, 5 adenoid cystic carcinoma and 1 acinic cell carcinoma. Compared to s TNBC, c TNBC was associated with high histologic grade(P<0.001) and lower androgen receptor(AR) expression(P<0.001). TNM stage of low-grade c TNBC was significantly lower than that of high-grade c TNBC(P=0.002). Although no significant difference, there was a trend that the rate of 5-year disease-free survival(DFS) and 5-year overall survival(OS) were longer in high-grade c TNBC than in high-grade s TNBC(P=0.091 and 0.518), and were longer in low-grade s TNBC than in high-grade s TNBC(P=0.051 and0.350). Metaplastic carcinomas showed larger tumor size(P=0.008) and higher proliferative Ki67 index(P=0.004)than c TNBCs.Conclusions: Results from our cohort imply that sub-categorization or subtyping and histological grading could be meaningful in pathological evaluation of TNBC, and need to be clarified in more large collections of TNBC.展开更多
The management of breast cancer,one of the most common and heterogeneous malignancies,has transformed with the advent of precision medicine.This review explores current developments in genetic profiling,molecular diag...The management of breast cancer,one of the most common and heterogeneous malignancies,has transformed with the advent of precision medicine.This review explores current developments in genetic profiling,molecular diagnostics,and targeted therapies that have revolutionized breast cancer treatment.Key innovations,such as cyclin-dependent kinases 4/6(CDK4/6)inhibitors,antibodydrug conjugates(ADCs),and immune checkpoint inhibitors(ICIs),have improved outcomes for hormone receptor-positive(HR+),HER2-positive(HER2+),and triple-negative breast cancer(TNBC)subtypes remarkably.Additionally,emerging treatments,such as PI3K inhibitors,poly(ADP-ribose)polymerase(PARP)inhibitors,and m RNA-based therapies,offer new avenues for targeting specific genetic mutations and improving treatment response,particularly in difficult-to-treat breast cancer subtypes.The integration of liquid biopsy technologies provides a non-invasive approach for real-time monitoring of tumor evolution and treatment response,thus enabling dynamic adjustments to therapy.Molecular imaging and artificial intelligence(AI)are increasingly crucial in enhancing diagnostic precision,personalizing treatment plans,and predicting therapeutic outcomes.As precision medicine continues to evolve,it has the potential to significantly improve survival rates,decrease recurrence,and enhance quality of life for patients with breast cancer.By combining cutting-edge diagnostics,personalized therapies,and emerging treatments,precision medicine can transform breast cancer care by offering more effective,individualized,and less invasive treatment options.展开更多
Objective:To explore the practical effectiveness of nursing intervention based on the theory of Gratitude Extension-Construction in improving the sense of hope in breast cancer patients.Methods:A total of 104 breast c...Objective:To explore the practical effectiveness of nursing intervention based on the theory of Gratitude Extension-Construction in improving the sense of hope in breast cancer patients.Methods:A total of 104 breast cancer patients treated in our hospital from January 2023 to May 2024 were included and divided into a control group(routine nursing,52 cases)and an observation group(routine nursing+nursing based on the theory of Gratitude Extension-Construction)using a random number table method.The Benefit Finding Scale(BFS),Hope Level Scale(HHI),and Quality of Life Questionnaire-Core 30(QLQ-C30)were used to compare and analyze the scores of the two groups before intervention,3 months after intervention,and 6 months after intervention.Results:There was no statistically significant difference in BFS,HHI,and QLQ-C30 scores between the two groups before intervention(P>0.05).Both BFS and HHI scores increased in the two groups at 3 and 6 months after intervention compared to before intervention(P<0.05),and the observation group had better BFS and HHI scores compared to the control group(P<0.05).Before intervention,there was no significant difference in QLQ-C30 scores between the two groups in all dimensions(P>0.05).Data comparison at 6 months after intervention showed that the observation group had better scores in all dimensions of QLQ-C30 than the control group(P<0.05).Conclusion:Nursing intervention based on the theory of Gratitude Extension-Construction can effectively improve the benefit-finding ability of postoperative breast cancer patients,enhance their level of hope,and improve their quality of life.It is worthy of promotion and application in clinical nursing.展开更多
Catalase(CAT)is a kind of tetrameric protein in the human body,play as a key regulator for controlling oxidative stress.The main function of CAT is to regulate the concentration of hydrogen peroxide(H2O2)by catalyzing...Catalase(CAT)is a kind of tetrameric protein in the human body,play as a key regulator for controlling oxidative stress.The main function of CAT is to regulate the concentration of hydrogen peroxide(H2O2)by catalyzing the decomposition of H2O2.At present,it is reported that CAT is also involved in regulating the oxidative stress in tumor cells,and its expression level is significantly related to the development of breast cancer(BC).In addition,CAT with different expression patterns,was related in the proliferation,invasion,treatment and prognosis of BC cells.Meanwhile,BC is a common and well-known cancer among women worldwide,and its incidence has been increasing in recent years.Therefore,in-depth study of CAT in the pathogenesis and progression of BC is of great significance for the future treatment and diagnosis.The present review summarized the effects of oxidative stress on cancer cells,and emphasized the key role of CAT in the development of BC,which provides a key clue for promoting research on BC and selecting therapeutic targets.展开更多
Objectives:While programmed cell death 1(PD-1)inhibitors have improved cancer treatment,the function and mechanisms of programmed cell death ligand 1(PD-L1),particularly when expressed by cancer cells,remain unclear.T...Objectives:While programmed cell death 1(PD-1)inhibitors have improved cancer treatment,the function and mechanisms of programmed cell death ligand 1(PD-L1),particularly when expressed by cancer cells,remain unclear.This study aims to explore the role of PD-L1 within breast cancer cells and identify key targets for future immunotherapy.Methods:RNA-seq was performed on breast cancer cells with silenced PD-L1 to screen for differentially expressed genes,followed by bioinformatics analysis.Clinical specimens from breast cancer patients undergoing primary surgery without preoperative treatment were collected,along with in vitro analysis to validate the potential mechanism.Results:RNA-seq data revealed a significant positive correlation between Ecto-5′-nucleotidase(NT5E)expression and PD-L1.Bioinformatics analysis corroborated this positive correlation.Immunohistochemistry staining demonstrated higher NT5E expression associated with increased lymph node metastasis.High expression of the NT5E gene was associated with poor overall survival(OS)in breast cancer patients,as determined by KM plotter analysis.Following PD-L1 gene silencing by siRNA in breast cancer cells,NT5E mRNA and protein expression significantly decreased.Conversely,no significant changes were observed in PD-L1 expression after NT5E gene silencing.In vitro experiments confirmed that cancer cell proliferation and metastasis abilities were significantly reduced by either PD-L1 or NT5E gene down-regulation.Western blotting demonstrated that PD-L1 expressed by cancer cells regulates NT5E expression through the MAPK/ERK signaling pathway.Conclusion:This study proposes a potential mechanism wherein tumor-expressing PD-L1 regulates NT5E through the MAPK/ERK pathway.Downregulation of PD-L1 or NT5E can significantly inhibit the proliferation and metastatic ability of cancer cells,potentially providing practical therapeutic targets and prognostic markers for combined PD-L1 immunotherapy in breast cancer.展开更多
Introduction The accuracy of sentinel lymph node biopsy(SLNB)after neoadjuvant therapy(NAT)has been confirmed in clinical nodal stage 1(c N1)patients,and more patients could benefit from axillary surgery de-escalation...Introduction The accuracy of sentinel lymph node biopsy(SLNB)after neoadjuvant therapy(NAT)has been confirmed in clinical nodal stage 1(c N1)patients,and more patients could benefit from axillary surgery de-escalation after NAT(1,2).展开更多
This is an erratum to the published paper titled,“High expression of autophagyrelated gene EIF4EBP1 could promote tamoxifen resistance and predict poor prognosis in breast cancer.”We have removed the citations to ce...This is an erratum to the published paper titled,“High expression of autophagyrelated gene EIF4EBP1 could promote tamoxifen resistance and predict poor prognosis in breast cancer.”We have removed the citations to certain articles in subsequent revisions of the manuscript.However,owing to our oversight,the citation marker in the upper right corner was not removed.We apologize for any confusion this may have caused.展开更多
BACKGROUND Breast cancer is one of the most common cancers among women worldwide,often leading to significant emotional and psychological stress.This stress is compounded by concerns about parenting roles and the pote...BACKGROUND Breast cancer is one of the most common cancers among women worldwide,often leading to significant emotional and psychological stress.This stress is compounded by concerns about parenting roles and the potential impact on children.Mindfulness-based cognitive therapy(MBCT)has shown promise in addressing anxiety and depressive symptoms.However,its effects on parenting anxiety and self-efficacy in patients with breast cancer are underexplored.AIM To evaluate the effects of MBCT on parenting anxiety,negative emotions,quality of life(QoL),and self-efficacy in patients with breast cancer.METHODS This retrospective study involved 249 patients with breast cancer admitted between January 2024 and December 2024.Participants were divided into two groups:The conventional treatment group(n=123)and the MBCT group(n=126),based on chosen treatment methods.Interventions lasted 8 weeks,with one session per week.Outcomes were measured using standardized questionnaires,including parenting anxiety[parenting concerns questionnaire(PCQ)],parenting sense of competence[parenting sense of competence scale(PSOCS)],negative emotions(self-rating anxiety scale and self-rating depression scale),hospital anxiety and depression[hospital anxiety and depression scale(HADS)],traumarelated distress[impact of event scale-revised(IES-R)],mindfulness(five-facet mindfulness questionnaire),QoL[functional assessment of cancer therapy-breast(FACT-B)],symptom severity(numeric rating scales),and self-efficacy[general self-efficacy scale(GSES)].RESULTS Post-treatment,the MBCT group showed a marked reduction in parenting anxiety scores(PCQ:MBCT 50.54±4.65 vs conventional 52.12±5.53,P=0.016)and notable improvement in parenting competence(PSOCS total:MBCT 61.56±4.65 vs conventional 59.75±4.96,P=0.003).The MBCT group also exhibited significant reductions in anxiety(HADS anxiety:MBCT 6.78±1.65 vs conventional 7.31±2.08,P=0.027)and trauma-related distress(IES-R intrusion:P=0.030;avoidance:P=0.004;hyperarousal:P=0.035).QoL scores significantly improved in the MBCT group in terms of physiological condition(FACT-B:MBCT 13.85±3.93 vs conventional 12.55±2.75,P=0.003)and functional status(P=0.010).Enhanced self-efficacy was observed in strategic effectiveness(GSES:MBCT 9.87±0.75 vs conventional 9.72±0.13,P=0.029).CONCLUSION MBCT significantly reduces parenting anxiety and enhances self-efficacy,QoL,and emotional regulation in patients with breast cancer.展开更多
BACKGROUND Chemotherapy for triple-negative breast cancer(TNBC)is often limited in efficacy due to drug resistance.The NOTCH1 pathway significantly contributes to the advancement of tumors,but its mechanism of action ...BACKGROUND Chemotherapy for triple-negative breast cancer(TNBC)is often limited in efficacy due to drug resistance.The NOTCH1 pathway significantly contributes to the advancement of tumors,but its mechanism of action in sensitizing TNBC to chemotherapy and its association with the downstream molecule,NT5E,is unclear.AIM To explore the molecular mechanisms by which NOTCH1 regulates cisplatin sensitivity in TNBC cells,and to validate its synergistic effect with NT5E.METHODS Expression of NOTCH1 in MDA-MB-231 cells was silenced using RNA interference,and the changes in cell proliferation,migration and cisplatin sensitivity were measured in combination with cell function experiments.The regulatory relationship between NOTCH1 and NT5E was analyzed using qPCR and Western blotting,and the silencing effect of NOTCH1 was verified using NT5E overexpression experiments.RESULTS Knockdown of NOTCH1 hindered the growth and motility of TNBC cells and lowered cisplatin’s half-maximal inhibitory concentration.Expression of NOTCH1 and NT5E was positively correlated,and NOTCH1 silencing led to a decrease in the expression of NT5E.Elevated NT5E expression attenuated the suppressive effects of NOTCH1 knockdown on both cell proliferation and cisplatin response.CONCLUSION NOTCH1 enhances TNBC cisplatin chemosensitivity by regulating NT5E expression.This study provides a new target and experimental basis for the development of combination therapy strategies for TNBC.展开更多
Following the publication of Zeng et al.(2023),an inadvertent error was recently identified in Figure 1B and Supplementary Figure S3.To ensure the accuracy and integrity of our published work,we formally request a cor...Following the publication of Zeng et al.(2023),an inadvertent error was recently identified in Figure 1B and Supplementary Figure S3.To ensure the accuracy and integrity of our published work,we formally request a correction to address this issue and apologize for any confusion this error may have caused.For details,please refer to the modified Supplementary Materials.展开更多
The“Global Cancer Statistics Report 2022”estimates that there were approximately 20 million new cancer cases worldwide,including 9.7 million in females,of which 2.31 million were breast cancer cases1.Breast cancer i...The“Global Cancer Statistics Report 2022”estimates that there were approximately 20 million new cancer cases worldwide,including 9.7 million in females,of which 2.31 million were breast cancer cases1.Breast cancer is the most common malignant tumor in women and one of the leading causes of cancer-related deaths.展开更多
Objective: Tumor-associated macrophages(TAMs) exhibit heterogeneous properties including anti-tumorigenic and protumorigenic phenotypes. The rate-limiting enzyme in de novo serine biosynthesis, 3-phosphoglycerate dehy...Objective: Tumor-associated macrophages(TAMs) exhibit heterogeneous properties including anti-tumorigenic and protumorigenic phenotypes. The rate-limiting enzyme in de novo serine biosynthesis, 3-phosphoglycerate dehydrogenase(PHGDH), has a well-established role in cellular metabolism, yet its specific role in macrophages remains unknown.Methods: Metabolomics assays were conducted to assess metabolite composition and dynamics in macrophages. Changes in polarization and immunosuppressive markers were validated with q RT-PCR. Bioinformatics was used to analyze immune cell subsets and associated metabolic pathways. Finally, Ch IP-q PCR and co-immunoprecipitation assays were performed to elucidate the downstream regulatory mechanisms of PHGDH.Results: Serine metabolism was found to be downregulated in TAMs in breast cancer. Functional studies revealed that PHGDH inhibition promotes an M2-like phenotype and immunosuppressive functions in macrophages. Furthermore, PHGDH was found to undergo nuclear translocation during macrophage polarization. Mechanistically, nuclear PHGDH was found to regulate GLUD1 and GLS2 transcription via interaction with the transcription factor STAT3. Rescue experiments demonstrated that glutamine supplementation and STAT3 inhibition reversed the effects of PHGDH on macrophage function.Conclusions: Our findings reveal a previously unrecognized non-canonical metabolic function of PHGDH, thus providing potential therapeutic targets in the tumor microenvironment for reversing malignant progression.展开更多
Background Regular physical training induces adaptive effects across multiple organ systems,highlighting the existence of inter-organ communication networks.However,the molecular mechanisms underlying both exercise-in...Background Regular physical training induces adaptive effects across multiple organ systems,highlighting the existence of inter-organ communication networks.However,the molecular mechanisms underlying both exercise-induced adaptations and organ-to-organ signaling are not fully characterized.Circulating extracellular vesicles(EVs),including exosomes,carry molecules like microRNAs(miRNAs)that may mediate tissue crosstalk.This study aimed to identify specific exercise training-responsive miRNAs that affect skeletal muscle function.Methods miRNA expression profiles of serum-derived EVs were analyzed in healthy young individuals before and after 3 weeks endurance exercise training.Exercise training-responsive miRNAs were then validated for a functional role in cellular metabolic processes in human myotubes.Results We identified several exercise training-responsive miRNAs within exosome-rich EVs in serum,including miR-136-3p.In human myotubes,miR-136-3p enhanced glucose uptake and targeted the nardilysin convertase(NRDC)gene.Transfection of miR-136-3p or silencing of NRDC induced a shift towards glycolytic metabolism in mitochondria and modulated gene expressions related to myogenesis.Pancreatic islets were identified as a potential source of miR-136-3p based on in silico analysis of gene expression and a molecular analysis of conditioned media from isolated pancreatic islets.Conclusion MiR-136-3p is an endurance training-responsive molecular transducer that modulates glucose metabolism and cellular proliferation in myocytes.Associated with EVs,extracellular miR-136-3p may serve as a molecular messenger to communicate islet–skeletal muscle crosstalk after exercise.Extracellular miR-136-3p may serve as a molecular messenger to communicate islet–skeletal muscle crosstalk.Our results highlight a miRNA-mediated mechanism that participates in inter-organ communication to fine tune the metabolic adaptations to exercise.展开更多
BACKGROUND Approximately 30%of patients with head and neck cancer experience adverse effects caused by anxiety and depression.Considering the high prevalence,implementing customized interventions to ease adverse emoti...BACKGROUND Approximately 30%of patients with head and neck cancer experience adverse effects caused by anxiety and depression.Considering the high prevalence,implementing customized interventions to ease adverse emotional states is imperative.AIM To evaluate the efficacy of cognitive behavioral therapy(CBT)-based psychological interventions in improving the psychological well-being and quality of life(QoL)of patients with laryngeal carcinoma.METHODS This study enrolled 120 patients admitted from February 2022 to February 2024.The control group,comprising 50 participants,received standard supportive psychological care,while the research group,consisting 70 participants,underwent CBT-based interventions.Several clinical outcomes were systematically assessed that included postoperative recovery metrics(duration of tracheostomy and nasogastric tube dependence and length of hospitalization),psychological status(Self-Rating Anxiety Scale and Self-Rating Depression Scale),nutritional markers(serum albumin and hemoglobin levels),sleep quality(Self-Rating Scale of Sleep and Athens Insomnia Scale),and QoL(Functional Assessment of Cancer Therapy-Head and Neck).RESULTS The results demonstrated that the research group experienced superior outcomes,with significantly reduced durations of tracheostomy and nasogastric tube dependence,as well as shorter hospital stays,compared with the control group.Additionally,the research group exhibited markedly lower post-intervention Self-Rating Anxiety Scale,Self-Rating Depression Scale,Self-Rating Scale of Sleep,and Athens Insomnia Scale scores,along with minimal but higher change in serum albumin and hemoglobin levels compared with the control group.All five domains of Functional Assessment of Cancer Therapy-Head and Neck showed notable improvements in the research group,exceeding those observed in the control group.CONCLUSION CBT-based psychological support positively affects the mental well-being and QoL of patients with laryngeal carcinoma,highlighting its potential for broader clinical application.展开更多
This study presents an approach to enhanced cancer immunotherapy through the in situ synthesis of potassium permanganate(KMnO_(4))derived manganese dioxide(MnO_(2))micro/nano-adjuvants.Addressing the limitations of tr...This study presents an approach to enhanced cancer immunotherapy through the in situ synthesis of potassium permanganate(KMnO_(4))derived manganese dioxide(MnO_(2))micro/nano-adjuvants.Addressing the limitations of traditional immunotherapy due to patient variability and the complexity of the tumor microenvironment,our research establishes KMnO_(4)as a potent immunomodulator that enhances the efficacy of anti-programmed death-ligand 1(αPD-L1)antibodies.The in situ synthesized MnO_(2)adjuvants in the tumor exhibit direct interactions with biological systems,leading to the reduction of MnO_(2)to Mn^(2+)within the tumor,and thereby improving the microenvironment for immune cell activity.Our in vitro and in vivo models demonstrate KMnO_(4)’s capability to induce concentration-dependent cytotoxicity in tumor cells,triggering DNA damage and apoptosis.It also potentiates immunogenic cell death by upregulating calreticulin and high mobility group box 1(HMGB1)on the cell surface.The combination of KMnO_(4)withαPD-L1 antibodies substantially inhibits tumor growth,promotes dendritic cell maturation,and enhances CD8^(+)T cell infiltration,resulting in a significant phenotypic shift in tumor-associated macrophages towards a pro-inflammatory M1 profile.Our findings advocate for further research into the long-term efficacy of KMnO_(4)and its application in diverse tumor models,emphasizing its potential to redefine immune checkpoint blockade therapy and offering a new vista in the fight against cancer.展开更多
Background:Neoadjuvant chemotherapy(NAC)significantly enhances clinical outcomes in patients with triple-negative breast cancer(TNBC);however,chemoresistance frequently results in treatment failure.Consequently,unders...Background:Neoadjuvant chemotherapy(NAC)significantly enhances clinical outcomes in patients with triple-negative breast cancer(TNBC);however,chemoresistance frequently results in treatment failure.Consequently,understanding the mechanisms underlying resistance and accurately predicting this phenomenon are crucial for improving treatment efficacy.Methods:Ultrasound images from 62 patients,taken before and after neoadjuvant therapy,were collected.Mitochondrial-related genes were extracted from a public database.Ultrasound features associated with NAC resistance were identified and correlated with significant mitochondrial-related genes.Subsequently,a prognostic model was developed and evaluated using the GSE58812 dataset.We also assessed this model alongside clinical factors and its ability to predict immunotherapy response.Results:A total of 32 significant differentially expressed genes in TNBC across three groups indicated a strong correlation with ultrasound features.Univariate and multivariate Cox regression analyses identified six genes as independent risk factors for TNBC prognosis.Based on these six mitochondrial-related genes,we constructed a TNBC prognostic model.The model’s risk scores indicated that high-risk patients generally have a poorer prognosis compared to low-risk patients,with the model demonstrating high predictive performance(p=0.002,AUC=0.745).This conclusion was further supported in the test set(p=0.026,AUC=0.718).Additionally,we found that high-risk patients exhibited more advanced tumor characteristics,while low-risk patients were more sensitive to common chemotherapy drugs and immunotherapy.The signature-related genes also predicted immunotherapy response with a high accuracy of 0.765.Conclusion:We identified resistance-related features from ultrasound images and integrated them with genomic data,enabling effective risk stratification of patients and prediction of the efficacy of neoadjuvant chemotherapy and immunotherapy in patients with TNBC.展开更多
Objective:To evaluate the efficacy and safety of QL1206(a denosumab biosimilar to Xgeva■)in breast cancer patients with bone metastasis(BM)through subgroup analysis of a randomized,double-blind phaseⅢtrial(No.NCT045...Objective:To evaluate the efficacy and safety of QL1206(a denosumab biosimilar to Xgeva■)in breast cancer patients with bone metastasis(BM)through subgroup analysis of a randomized,double-blind phaseⅢtrial(No.NCT04550949).Methods:This subgroup analysis included patients with BM from breast cancer enrolled in a phaseⅢtrial.Patients were randomized(1:1)to receive either three cycles of QL1206 or denosumab(120 mg subcutaneously every 4 weeks).Subsequently,they received 10 cycles of QL1206(120 mg)over 40 weeks,followed by a 20-week safety follow-up.The primary endpoint was the percentage changes from baseline to week 13 in urinary Ntelopeptide corrected for creatinine(u NTx/Cr).Results:The breast cancer cohort consisted of 311 patients.Vertebral involvement(66.4%)was the most prevalent BM site at enrollment,while 27.7%of patients presented with≥3 metastatic bone lesions.At week 13,QL1206 demonstrated a median u NTx/Cr reduction of-69.9%(range:-98.1%-568.0%)vs.-74.3%(range:-97.7%-386.3%)for denosumab.The analysis of covariance revealed comparable least-square means for log-transformed changes:-1.416[95%confidence interval(95%CI):-1.736 to-1.096]vs.-1.501(95%CI:-1.824 to-1.178),yielding an between-group difference of 0.085(90%CI:-0.062-0.232;P=0.343).After a 53-week treatment period,83.6%achieved bone density improvement/disease stabilization.Safety profiles were comparable between groups.Conclusions:QL1206 demonstrated similar efficacy and safety to the reference denosumab in patients with BM from breast cancer,supporting QL1206 as a new option for management of BM from breast cancer.展开更多
Objective： Early assessment of response to neoadjuvant chemotherapy （NAC） for breast cancer allows therapy to be individualized. The optimal assessment method has not been established. We investigated the accuracy ...Objective： Early assessment of response to neoadjuvant chemotherapy （NAC） for breast cancer allows therapy to be individualized. The optimal assessment method has not been established. We investigated the accuracy of automated breast ultrasound （ABUS） to predict pathological outcomes after NAC. Methods： A total of 290 breast cancer patients were eligible for this study. Tumor response after 2 cycles of chemotherapy was assessed using the product change of two largest perpendicular diameters （PC） or the longest diameter change （LDC）. PC and LDC were analyzed on the axial and the coronal planes respectively. Receiver operating characteristic （ROC） curves were used to evaluate overall performance of the prediction methods. Youden＇s indexes were calculated to select the optimal cut-off value for each method. Sensitivity, specificity, positive and negative predictive values （PPV and NPV） and the area under the ROC curve （AUC） were calculated accordingly.Results： ypT0/is was achieved in 42 patients （14.5%） while ypT0 was achieved in 30 patients （10.3%） after NAC. All four prediction methods （PC on axial planes, LDC on axial planes, PC on coronal planes and LDC on coronal planes） displayed high AUCs （all〉0.82）, with the highest of 0.89 [95% confidence interval （95% CI）, 0.83-0.95] when mid-treatment ＆BUS was used to predict final pathological complete remission （pCR）. High sensitivities （85.7%-88.1%） were observed across all four prediction methods while high specificities （81.5%-85.1%） were observed in two methods used PC. The optimal cut-off values defined by our data replicate the WHO and the RECIST criteria. Lower AUCs were observed when mid-treatment ABUS was used to predict poor pathological outcomes. Conclusions：ABUS is a useful tool in early evaluation of pCR after NAC while less reliable when predicting poor pathological outcomes.展开更多
基金funded by the medical and health category of the Science and Technology Project of Shantou(No.230509116495542,Wu Haoming)National Natural Science Foundation of China(NSFC)Cultivation Project of the Cancer Hospital of Shantou University Medical College(No.2024GP002,Wu Haoming)National Natural Science Foundation of China(82203130,Ye Feng).
文摘Background:Breast cancer remains a leading cause of morbidity and mortality among women worldwide,with significant geographic disparities in its impact.While human epidermal growth factor receptor 2(HER2)-targeted therapies,such as trastuzumab,have improved outcomes for HER2-positive breast cancer,challenges like therapy resistance persist,highlighting the need for novel treatments.Recent developments in antibody-drug conjugates(ADCs),particularly disitamab vedotin(RC48),show promising efficacy in targeting both HER2-positive and HER2-low expression tumors,warranting further investigation through real-world studies to assess its broader clinical applicability.Method:This retrospective,multicenter observational study evaluated the real-world efficacy and safety of RC48 in patients with HER2-positive or HER2-low breast cancer across three medical centers in China.Patient demographic characteristics,treatment patterns,sequential use of ADCs,and treatment-related adverse events were recorded and analyzed.Result:The median progression-free survival(mPFS)for the overall population(n 96)was=4.31 months,with HER2-positive patients demonstrating significantly longer mPFS(5.26 months)compared to HER2-low patients(3.45 months;p<0.044),while subgroup analyses revealed no significant differences in mPFS based on=estrogen receptor(ER),progesterone receptor(PR),or hormone receptor(HR)status.Safety data indicated that adverse events were consistent with prior reports,with no new safety concerns identified during the study period.Conclusion:This real-world study demonstrates the efficacy of RC48 in both HER2-positive and HER2-low breast cancer.Notably,combination therapy significantly improved outcomes in HER2-low patients.
基金supported by grants from the National Natural Science Foundation of China(Grant Nos.81672638 and W2421095)National Natural Science Foundation of Shandong Province(Grant No.ZR2024LMB011)Collaborative Academic Innovation Project of Shandong Cancer Hospital(Grant No.GF003)。
文摘The principal breast cancer treatment approach has long been surgical removal of the primary breast lesions and regional lymph nodes,particularly the axillary lymph nodes.However,the advent of minimally invasive diagnostic techniques,such as sentinel lymph node biopsy(SLNB),has markedly diminished the extent of surgery required for regional lymph nodes.
基金supported by the National Key R&D Program of China (No.2016YFC0901302)。
文摘Objective: To investigate histo-pathological distribution and clinico-pathological significance in a large Chinese triple-negative breast cancer(TNBC) patients serials based on the latest understanding of its clinico-pathological diversity, and to provide more information to clinicians to improve precision of individualized treatment of TNBC.Methods: A retrospective analysis was performed on patients with TNBC at Breast Disease Center, Peking University First Hospital between January 2010 and December 2019. Histo-and clinico-pathological characteristics were analyzed by Chi-square test and Student's t-test, and prognoses were calculated using KaplanMeier method and a Cox proportionate hazards model. Bonferroni correction was used to correct for multiple comparison.Results: Conventional type of TNBC(c TNBC) were identified in 73.7% of 582 TNBC, while special type of TNBC(s TNBC) were 26.3%, including 71 apocrine carcinoma, 20 medullary carcinoma, 31 metaplastic carcinoma, 18 invasive lobular carcinoma, 7 invasive micropapillary carcinoma, 5 adenoid cystic carcinoma and 1 acinic cell carcinoma. Compared to s TNBC, c TNBC was associated with high histologic grade(P<0.001) and lower androgen receptor(AR) expression(P<0.001). TNM stage of low-grade c TNBC was significantly lower than that of high-grade c TNBC(P=0.002). Although no significant difference, there was a trend that the rate of 5-year disease-free survival(DFS) and 5-year overall survival(OS) were longer in high-grade c TNBC than in high-grade s TNBC(P=0.091 and 0.518), and were longer in low-grade s TNBC than in high-grade s TNBC(P=0.051 and0.350). Metaplastic carcinomas showed larger tumor size(P=0.008) and higher proliferative Ki67 index(P=0.004)than c TNBCs.Conclusions: Results from our cohort imply that sub-categorization or subtyping and histological grading could be meaningful in pathological evaluation of TNBC, and need to be clarified in more large collections of TNBC.
基金supported by grants from the National Natural Science Foundation of China(Grant Nos.82103614 and 32171363)Natural Science Foundation of Fujian Province of China(Grant No.2021J05007)+4 种基金funding from the start-up fund for Fujian Key Laboratory of Precision Diagnosis and Treatment in Breast CancerXiamen’s Key Laboratory of Precision Medicine for Endocrine-Related Cancersstart-up and supporting funds from the Third Affiliated Hospital of Kunming Medical University,Yunnan Cancer Hospital for Guo-Jun Zhang and Jing-Wen BaiKey Research and development program for social development of Yunnan Science and Technology Department(Grant No.202403AC100014-2)horizontal project funding from the Third Affiliated Hospital of Kunming Medical University(Grant Nos.20233160A0866 and 20243160A0511)。
文摘The management of breast cancer,one of the most common and heterogeneous malignancies,has transformed with the advent of precision medicine.This review explores current developments in genetic profiling,molecular diagnostics,and targeted therapies that have revolutionized breast cancer treatment.Key innovations,such as cyclin-dependent kinases 4/6(CDK4/6)inhibitors,antibodydrug conjugates(ADCs),and immune checkpoint inhibitors(ICIs),have improved outcomes for hormone receptor-positive(HR+),HER2-positive(HER2+),and triple-negative breast cancer(TNBC)subtypes remarkably.Additionally,emerging treatments,such as PI3K inhibitors,poly(ADP-ribose)polymerase(PARP)inhibitors,and m RNA-based therapies,offer new avenues for targeting specific genetic mutations and improving treatment response,particularly in difficult-to-treat breast cancer subtypes.The integration of liquid biopsy technologies provides a non-invasive approach for real-time monitoring of tumor evolution and treatment response,thus enabling dynamic adjustments to therapy.Molecular imaging and artificial intelligence(AI)are increasingly crucial in enhancing diagnostic precision,personalizing treatment plans,and predicting therapeutic outcomes.As precision medicine continues to evolve,it has the potential to significantly improve survival rates,decrease recurrence,and enhance quality of life for patients with breast cancer.By combining cutting-edge diagnostics,personalized therapies,and emerging treatments,precision medicine can transform breast cancer care by offering more effective,individualized,and less invasive treatment options.
文摘Objective:To explore the practical effectiveness of nursing intervention based on the theory of Gratitude Extension-Construction in improving the sense of hope in breast cancer patients.Methods:A total of 104 breast cancer patients treated in our hospital from January 2023 to May 2024 were included and divided into a control group(routine nursing,52 cases)and an observation group(routine nursing+nursing based on the theory of Gratitude Extension-Construction)using a random number table method.The Benefit Finding Scale(BFS),Hope Level Scale(HHI),and Quality of Life Questionnaire-Core 30(QLQ-C30)were used to compare and analyze the scores of the two groups before intervention,3 months after intervention,and 6 months after intervention.Results:There was no statistically significant difference in BFS,HHI,and QLQ-C30 scores between the two groups before intervention(P>0.05).Both BFS and HHI scores increased in the two groups at 3 and 6 months after intervention compared to before intervention(P<0.05),and the observation group had better BFS and HHI scores compared to the control group(P<0.05).Before intervention,there was no significant difference in QLQ-C30 scores between the two groups in all dimensions(P>0.05).Data comparison at 6 months after intervention showed that the observation group had better scores in all dimensions of QLQ-C30 than the control group(P<0.05).Conclusion:Nursing intervention based on the theory of Gratitude Extension-Construction can effectively improve the benefit-finding ability of postoperative breast cancer patients,enhance their level of hope,and improve their quality of life.It is worthy of promotion and application in clinical nursing.
基金Supported by National Natural Science Foundation of China,No.82273457Natural Science Foundation of Guangdong Province,No.2023A1515012762Science and Technology Special Project of Guangdong Province,No.210715216902829.
文摘Catalase(CAT)is a kind of tetrameric protein in the human body,play as a key regulator for controlling oxidative stress.The main function of CAT is to regulate the concentration of hydrogen peroxide(H2O2)by catalyzing the decomposition of H2O2.At present,it is reported that CAT is also involved in regulating the oxidative stress in tumor cells,and its expression level is significantly related to the development of breast cancer(BC).In addition,CAT with different expression patterns,was related in the proliferation,invasion,treatment and prognosis of BC cells.Meanwhile,BC is a common and well-known cancer among women worldwide,and its incidence has been increasing in recent years.Therefore,in-depth study of CAT in the pathogenesis and progression of BC is of great significance for the future treatment and diagnosis.The present review summarized the effects of oxidative stress on cancer cells,and emphasized the key role of CAT in the development of BC,which provides a key clue for promoting research on BC and selecting therapeutic targets.
基金Provincial Natural Science Foundation J230016Provincial Natural Science Foundation H2023206441Hebei Province Major Science and Technology Support Program Project S&T Program of Hebei 242W7701Z.
文摘Objectives:While programmed cell death 1(PD-1)inhibitors have improved cancer treatment,the function and mechanisms of programmed cell death ligand 1(PD-L1),particularly when expressed by cancer cells,remain unclear.This study aims to explore the role of PD-L1 within breast cancer cells and identify key targets for future immunotherapy.Methods:RNA-seq was performed on breast cancer cells with silenced PD-L1 to screen for differentially expressed genes,followed by bioinformatics analysis.Clinical specimens from breast cancer patients undergoing primary surgery without preoperative treatment were collected,along with in vitro analysis to validate the potential mechanism.Results:RNA-seq data revealed a significant positive correlation between Ecto-5′-nucleotidase(NT5E)expression and PD-L1.Bioinformatics analysis corroborated this positive correlation.Immunohistochemistry staining demonstrated higher NT5E expression associated with increased lymph node metastasis.High expression of the NT5E gene was associated with poor overall survival(OS)in breast cancer patients,as determined by KM plotter analysis.Following PD-L1 gene silencing by siRNA in breast cancer cells,NT5E mRNA and protein expression significantly decreased.Conversely,no significant changes were observed in PD-L1 expression after NT5E gene silencing.In vitro experiments confirmed that cancer cell proliferation and metastasis abilities were significantly reduced by either PD-L1 or NT5E gene down-regulation.Western blotting demonstrated that PD-L1 expressed by cancer cells regulates NT5E expression through the MAPK/ERK signaling pathway.Conclusion:This study proposes a potential mechanism wherein tumor-expressing PD-L1 regulates NT5E through the MAPK/ERK pathway.Downregulation of PD-L1 or NT5E can significantly inhibit the proliferation and metastatic ability of cancer cells,potentially providing practical therapeutic targets and prognostic markers for combined PD-L1 immunotherapy in breast cancer.
文摘Introduction The accuracy of sentinel lymph node biopsy(SLNB)after neoadjuvant therapy(NAT)has been confirmed in clinical nodal stage 1(c N1)patients,and more patients could benefit from axillary surgery de-escalation after NAT(1,2).
文摘This is an erratum to the published paper titled,“High expression of autophagyrelated gene EIF4EBP1 could promote tamoxifen resistance and predict poor prognosis in breast cancer.”We have removed the citations to certain articles in subsequent revisions of the manuscript.However,owing to our oversight,the citation marker in the upper right corner was not removed.We apologize for any confusion this may have caused.
基金Supported by Hebei Provincial Health Commission Research Fund,No.20241695.
文摘BACKGROUND Breast cancer is one of the most common cancers among women worldwide,often leading to significant emotional and psychological stress.This stress is compounded by concerns about parenting roles and the potential impact on children.Mindfulness-based cognitive therapy(MBCT)has shown promise in addressing anxiety and depressive symptoms.However,its effects on parenting anxiety and self-efficacy in patients with breast cancer are underexplored.AIM To evaluate the effects of MBCT on parenting anxiety,negative emotions,quality of life(QoL),and self-efficacy in patients with breast cancer.METHODS This retrospective study involved 249 patients with breast cancer admitted between January 2024 and December 2024.Participants were divided into two groups:The conventional treatment group(n=123)and the MBCT group(n=126),based on chosen treatment methods.Interventions lasted 8 weeks,with one session per week.Outcomes were measured using standardized questionnaires,including parenting anxiety[parenting concerns questionnaire(PCQ)],parenting sense of competence[parenting sense of competence scale(PSOCS)],negative emotions(self-rating anxiety scale and self-rating depression scale),hospital anxiety and depression[hospital anxiety and depression scale(HADS)],traumarelated distress[impact of event scale-revised(IES-R)],mindfulness(five-facet mindfulness questionnaire),QoL[functional assessment of cancer therapy-breast(FACT-B)],symptom severity(numeric rating scales),and self-efficacy[general self-efficacy scale(GSES)].RESULTS Post-treatment,the MBCT group showed a marked reduction in parenting anxiety scores(PCQ:MBCT 50.54±4.65 vs conventional 52.12±5.53,P=0.016)and notable improvement in parenting competence(PSOCS total:MBCT 61.56±4.65 vs conventional 59.75±4.96,P=0.003).The MBCT group also exhibited significant reductions in anxiety(HADS anxiety:MBCT 6.78±1.65 vs conventional 7.31±2.08,P=0.027)and trauma-related distress(IES-R intrusion:P=0.030;avoidance:P=0.004;hyperarousal:P=0.035).QoL scores significantly improved in the MBCT group in terms of physiological condition(FACT-B:MBCT 13.85±3.93 vs conventional 12.55±2.75,P=0.003)and functional status(P=0.010).Enhanced self-efficacy was observed in strategic effectiveness(GSES:MBCT 9.87±0.75 vs conventional 9.72±0.13,P=0.029).CONCLUSION MBCT significantly reduces parenting anxiety and enhances self-efficacy,QoL,and emotional regulation in patients with breast cancer.
基金Supported by National Natural Science Foundation of China,No.82273457the Natural Science Foundation of Guangdong Province,No.2021A1515012180 and No.2023A1515012762+1 种基金Science and Technology Special Project of Guangdong Province,No.210715216902829 and No.200628175260810‘Dengfeng Project’for the Construction of High-Level Hospitals in Guangdong Province—First Affiliated Hospital of Shantou University College Supporting Funding,No.202003-10.
文摘BACKGROUND Chemotherapy for triple-negative breast cancer(TNBC)is often limited in efficacy due to drug resistance.The NOTCH1 pathway significantly contributes to the advancement of tumors,but its mechanism of action in sensitizing TNBC to chemotherapy and its association with the downstream molecule,NT5E,is unclear.AIM To explore the molecular mechanisms by which NOTCH1 regulates cisplatin sensitivity in TNBC cells,and to validate its synergistic effect with NT5E.METHODS Expression of NOTCH1 in MDA-MB-231 cells was silenced using RNA interference,and the changes in cell proliferation,migration and cisplatin sensitivity were measured in combination with cell function experiments.The regulatory relationship between NOTCH1 and NT5E was analyzed using qPCR and Western blotting,and the silencing effect of NOTCH1 was verified using NT5E overexpression experiments.RESULTS Knockdown of NOTCH1 hindered the growth and motility of TNBC cells and lowered cisplatin’s half-maximal inhibitory concentration.Expression of NOTCH1 and NT5E was positively correlated,and NOTCH1 silencing led to a decrease in the expression of NT5E.Elevated NT5E expression attenuated the suppressive effects of NOTCH1 knockdown on both cell proliferation and cisplatin response.CONCLUSION NOTCH1 enhances TNBC cisplatin chemosensitivity by regulating NT5E expression.This study provides a new target and experimental basis for the development of combination therapy strategies for TNBC.
文摘Following the publication of Zeng et al.(2023),an inadvertent error was recently identified in Figure 1B and Supplementary Figure S3.To ensure the accuracy and integrity of our published work,we formally request a correction to address this issue and apologize for any confusion this error may have caused.For details,please refer to the modified Supplementary Materials.
基金supported by grants from the National Natural Science Foundation of China(Grant No.81672638)。
文摘The“Global Cancer Statistics Report 2022”estimates that there were approximately 20 million new cancer cases worldwide,including 9.7 million in females,of which 2.31 million were breast cancer cases1.Breast cancer is the most common malignant tumor in women and one of the leading causes of cancer-related deaths.
基金supported by grants from the National Key R&D Program of China (Grant No. 2022YFC3401001)National Natural Science Foundation of China (Grant Nos. 82025026 and 82230091 to H.H.)+1 种基金Key R&D Program of Zhejiang (Grant No. 2024C03160)Guang Dong Basic and Applied Basic Research Foundation (Grant Nos. 2023A1515012412 and 2023A1515011214)。
文摘Objective: Tumor-associated macrophages(TAMs) exhibit heterogeneous properties including anti-tumorigenic and protumorigenic phenotypes. The rate-limiting enzyme in de novo serine biosynthesis, 3-phosphoglycerate dehydrogenase(PHGDH), has a well-established role in cellular metabolism, yet its specific role in macrophages remains unknown.Methods: Metabolomics assays were conducted to assess metabolite composition and dynamics in macrophages. Changes in polarization and immunosuppressive markers were validated with q RT-PCR. Bioinformatics was used to analyze immune cell subsets and associated metabolic pathways. Finally, Ch IP-q PCR and co-immunoprecipitation assays were performed to elucidate the downstream regulatory mechanisms of PHGDH.Results: Serine metabolism was found to be downregulated in TAMs in breast cancer. Functional studies revealed that PHGDH inhibition promotes an M2-like phenotype and immunosuppressive functions in macrophages. Furthermore, PHGDH was found to undergo nuclear translocation during macrophage polarization. Mechanistically, nuclear PHGDH was found to regulate GLUD1 and GLS2 transcription via interaction with the transcription factor STAT3. Rescue experiments demonstrated that glutamine supplementation and STAT3 inhibition reversed the effects of PHGDH on macrophage function.Conclusions: Our findings reveal a previously unrecognized non-canonical metabolic function of PHGDH, thus providing potential therapeutic targets in the tumor microenvironment for reversing malignant progression.
基金supported by grants from the Knut and Alice Wallenberg foundation(P-OB,JRZ,and AK)the Swedish Research Council(JRZ and AK),Centrum för idrottsforskning(AK and JRZ)+7 种基金the NovoNordisk Foundation Metabolic Stress Associated Molecules(MSAM)consortium NNF15SA0018346 and Metabolite-related Inflammation and Disease(MeRIAD)consortium Grant number 0064142(AK)the Swedish Diabetes Foundation(AK and JRZ)the European Foundation for the Study of Diabetes(JRZ and AK)the Region Stockholm(ALF project)(JRZ and KC)the Strategic Research Program in Diabetes at Karolinska Institutet(JRZ and AK)supported by the Strategic Research Programme in Diabetes(SRP Diabetes)for use of the Seahorse flux analyzer.Human islets were made possible through the Juvenile Diabetes Research Foundation(JDRF)award 31-2008-416(European Coordinating Infrastructure for Islet Transplantation(ECIT),Islet for Basic Research program)AK holds a Distinguished Investigator Grant within Endocrinology and Metabolism from the Novo Nordisk Foundation(NNF24OC0088739)JRZ received the 2024 European Association for the Study of Diabetes(ESAD)-Novo Nordisk Foundation Diabetes Prize for Excellence(NNF24SA0092609).
文摘Background Regular physical training induces adaptive effects across multiple organ systems,highlighting the existence of inter-organ communication networks.However,the molecular mechanisms underlying both exercise-induced adaptations and organ-to-organ signaling are not fully characterized.Circulating extracellular vesicles(EVs),including exosomes,carry molecules like microRNAs(miRNAs)that may mediate tissue crosstalk.This study aimed to identify specific exercise training-responsive miRNAs that affect skeletal muscle function.Methods miRNA expression profiles of serum-derived EVs were analyzed in healthy young individuals before and after 3 weeks endurance exercise training.Exercise training-responsive miRNAs were then validated for a functional role in cellular metabolic processes in human myotubes.Results We identified several exercise training-responsive miRNAs within exosome-rich EVs in serum,including miR-136-3p.In human myotubes,miR-136-3p enhanced glucose uptake and targeted the nardilysin convertase(NRDC)gene.Transfection of miR-136-3p or silencing of NRDC induced a shift towards glycolytic metabolism in mitochondria and modulated gene expressions related to myogenesis.Pancreatic islets were identified as a potential source of miR-136-3p based on in silico analysis of gene expression and a molecular analysis of conditioned media from isolated pancreatic islets.Conclusion MiR-136-3p is an endurance training-responsive molecular transducer that modulates glucose metabolism and cellular proliferation in myocytes.Associated with EVs,extracellular miR-136-3p may serve as a molecular messenger to communicate islet–skeletal muscle crosstalk after exercise.Extracellular miR-136-3p may serve as a molecular messenger to communicate islet–skeletal muscle crosstalk.Our results highlight a miRNA-mediated mechanism that participates in inter-organ communication to fine tune the metabolic adaptations to exercise.
文摘BACKGROUND Approximately 30%of patients with head and neck cancer experience adverse effects caused by anxiety and depression.Considering the high prevalence,implementing customized interventions to ease adverse emotional states is imperative.AIM To evaluate the efficacy of cognitive behavioral therapy(CBT)-based psychological interventions in improving the psychological well-being and quality of life(QoL)of patients with laryngeal carcinoma.METHODS This study enrolled 120 patients admitted from February 2022 to February 2024.The control group,comprising 50 participants,received standard supportive psychological care,while the research group,consisting 70 participants,underwent CBT-based interventions.Several clinical outcomes were systematically assessed that included postoperative recovery metrics(duration of tracheostomy and nasogastric tube dependence and length of hospitalization),psychological status(Self-Rating Anxiety Scale and Self-Rating Depression Scale),nutritional markers(serum albumin and hemoglobin levels),sleep quality(Self-Rating Scale of Sleep and Athens Insomnia Scale),and QoL(Functional Assessment of Cancer Therapy-Head and Neck).RESULTS The results demonstrated that the research group experienced superior outcomes,with significantly reduced durations of tracheostomy and nasogastric tube dependence,as well as shorter hospital stays,compared with the control group.Additionally,the research group exhibited markedly lower post-intervention Self-Rating Anxiety Scale,Self-Rating Depression Scale,Self-Rating Scale of Sleep,and Athens Insomnia Scale scores,along with minimal but higher change in serum albumin and hemoglobin levels compared with the control group.All five domains of Functional Assessment of Cancer Therapy-Head and Neck showed notable improvements in the research group,exceeding those observed in the control group.CONCLUSION CBT-based psychological support positively affects the mental well-being and QoL of patients with laryngeal carcinoma,highlighting its potential for broader clinical application.
基金supported by the Natural Science Foundation of Guangdong Province(No.2023A1515030291)the Dongguan Science and Technology of Social Development Program(No.20211800905282)+8 种基金the National Key Research and Development Program of China(Nos.2022YFC2303600,2020YFA0908000)the Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine(No.ZYYCXTDC-202002)the CACMS Innovation Fund(Nos.CI2023E002,CI2021A05101,CI2021A05104)the Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences(Nos.CI2023D003,CI2021B014)the Science and Technology Foundation of Shenzhen(No.JCYJ20210324115800001)the Science and Technology Foundation of Shenzhen(Shenzhen Clinical Medical Research Center for Geriatric Diseases)the Shenzhen Medical Research Fund(No.B2302051)the Distinguished Expert Project of Sichuan Province Tianfu Scholar(No.CW202002)Shenzhen Science and Technology Program(No.RCBS20210609104424065).
文摘This study presents an approach to enhanced cancer immunotherapy through the in situ synthesis of potassium permanganate(KMnO_(4))derived manganese dioxide(MnO_(2))micro/nano-adjuvants.Addressing the limitations of traditional immunotherapy due to patient variability and the complexity of the tumor microenvironment,our research establishes KMnO_(4)as a potent immunomodulator that enhances the efficacy of anti-programmed death-ligand 1(αPD-L1)antibodies.The in situ synthesized MnO_(2)adjuvants in the tumor exhibit direct interactions with biological systems,leading to the reduction of MnO_(2)to Mn^(2+)within the tumor,and thereby improving the microenvironment for immune cell activity.Our in vitro and in vivo models demonstrate KMnO_(4)’s capability to induce concentration-dependent cytotoxicity in tumor cells,triggering DNA damage and apoptosis.It also potentiates immunogenic cell death by upregulating calreticulin and high mobility group box 1(HMGB1)on the cell surface.The combination of KMnO_(4)withαPD-L1 antibodies substantially inhibits tumor growth,promotes dendritic cell maturation,and enhances CD8^(+)T cell infiltration,resulting in a significant phenotypic shift in tumor-associated macrophages towards a pro-inflammatory M1 profile.Our findings advocate for further research into the long-term efficacy of KMnO_(4)and its application in diverse tumor models,emphasizing its potential to redefine immune checkpoint blockade therapy and offering a new vista in the fight against cancer.
基金supported by Wu Jieping Medical Foundation(320.6750.2022-19-40 and 320.6750.2024-18-41)Guangxi University Young and Middle-Aged Teachers Research Basic Ability Improvement Project(2024KY0510)Guangxi Health Commission Self-Funded Research Project(Z-C20231002).
文摘Background:Neoadjuvant chemotherapy(NAC)significantly enhances clinical outcomes in patients with triple-negative breast cancer(TNBC);however,chemoresistance frequently results in treatment failure.Consequently,understanding the mechanisms underlying resistance and accurately predicting this phenomenon are crucial for improving treatment efficacy.Methods:Ultrasound images from 62 patients,taken before and after neoadjuvant therapy,were collected.Mitochondrial-related genes were extracted from a public database.Ultrasound features associated with NAC resistance were identified and correlated with significant mitochondrial-related genes.Subsequently,a prognostic model was developed and evaluated using the GSE58812 dataset.We also assessed this model alongside clinical factors and its ability to predict immunotherapy response.Results:A total of 32 significant differentially expressed genes in TNBC across three groups indicated a strong correlation with ultrasound features.Univariate and multivariate Cox regression analyses identified six genes as independent risk factors for TNBC prognosis.Based on these six mitochondrial-related genes,we constructed a TNBC prognostic model.The model’s risk scores indicated that high-risk patients generally have a poorer prognosis compared to low-risk patients,with the model demonstrating high predictive performance(p=0.002,AUC=0.745).This conclusion was further supported in the test set(p=0.026,AUC=0.718).Additionally,we found that high-risk patients exhibited more advanced tumor characteristics,while low-risk patients were more sensitive to common chemotherapy drugs and immunotherapy.The signature-related genes also predicted immunotherapy response with a high accuracy of 0.765.Conclusion:We identified resistance-related features from ultrasound images and integrated them with genomic data,enabling effective risk stratification of patients and prediction of the efficacy of neoadjuvant chemotherapy and immunotherapy in patients with TNBC.
文摘Objective:To evaluate the efficacy and safety of QL1206(a denosumab biosimilar to Xgeva■)in breast cancer patients with bone metastasis(BM)through subgroup analysis of a randomized,double-blind phaseⅢtrial(No.NCT04550949).Methods:This subgroup analysis included patients with BM from breast cancer enrolled in a phaseⅢtrial.Patients were randomized(1:1)to receive either three cycles of QL1206 or denosumab(120 mg subcutaneously every 4 weeks).Subsequently,they received 10 cycles of QL1206(120 mg)over 40 weeks,followed by a 20-week safety follow-up.The primary endpoint was the percentage changes from baseline to week 13 in urinary Ntelopeptide corrected for creatinine(u NTx/Cr).Results:The breast cancer cohort consisted of 311 patients.Vertebral involvement(66.4%)was the most prevalent BM site at enrollment,while 27.7%of patients presented with≥3 metastatic bone lesions.At week 13,QL1206 demonstrated a median u NTx/Cr reduction of-69.9%(range:-98.1%-568.0%)vs.-74.3%(range:-97.7%-386.3%)for denosumab.The analysis of covariance revealed comparable least-square means for log-transformed changes:-1.416[95%confidence interval(95%CI):-1.736 to-1.096]vs.-1.501(95%CI:-1.824 to-1.178),yielding an between-group difference of 0.085(90%CI:-0.062-0.232;P=0.343).After a 53-week treatment period,83.6%achieved bone density improvement/disease stabilization.Safety profiles were comparable between groups.Conclusions:QL1206 demonstrated similar efficacy and safety to the reference denosumab in patients with BM from breast cancer,supporting QL1206 as a new option for management of BM from breast cancer.
文摘Objective： Early assessment of response to neoadjuvant chemotherapy （NAC） for breast cancer allows therapy to be individualized. The optimal assessment method has not been established. We investigated the accuracy of automated breast ultrasound （ABUS） to predict pathological outcomes after NAC. Methods： A total of 290 breast cancer patients were eligible for this study. Tumor response after 2 cycles of chemotherapy was assessed using the product change of two largest perpendicular diameters （PC） or the longest diameter change （LDC）. PC and LDC were analyzed on the axial and the coronal planes respectively. Receiver operating characteristic （ROC） curves were used to evaluate overall performance of the prediction methods. Youden＇s indexes were calculated to select the optimal cut-off value for each method. Sensitivity, specificity, positive and negative predictive values （PPV and NPV） and the area under the ROC curve （AUC） were calculated accordingly.Results： ypT0/is was achieved in 42 patients （14.5%） while ypT0 was achieved in 30 patients （10.3%） after NAC. All four prediction methods （PC on axial planes, LDC on axial planes, PC on coronal planes and LDC on coronal planes） displayed high AUCs （all〉0.82）, with the highest of 0.89 [95% confidence interval （95% CI）, 0.83-0.95] when mid-treatment ＆BUS was used to predict final pathological complete remission （pCR）. High sensitivities （85.7%-88.1%） were observed across all four prediction methods while high specificities （81.5%-85.1%） were observed in two methods used PC. The optimal cut-off values defined by our data replicate the WHO and the RECIST criteria. Lower AUCs were observed when mid-treatment ABUS was used to predict poor pathological outcomes. Conclusions：ABUS is a useful tool in early evaluation of pCR after NAC while less reliable when predicting poor pathological outcomes.
